Today: May 23, 2024
January 19, 2024
1 min read

CerraCap Ventures Fuels Acorai, Propelling Revolutionary Heart Failure Management

A healthcare innovation venture capital firm, CerraCap Ventures, has invested in Acorai, a cardiovascular health technology company. The investment will support the development of Acorai’s Acorai Heart Monitor (AHM), a device designed to measure intracardiac pressures non-invasively, providing accurate and reliable data for heart failure management. With funding from CerraCap Ventures, Acorai plans to conduct global clinical studies to gain FDA approval and launch AHM in the market. This investment reflects CerraCap’s confidence in Acorai’s approach to enhancing patient outcomes and its commitment to transforming cardiovascular health.

Previous Story

Revolutionary Digital Onboarding Secures $58 Million for Unstoppable Growth

Next Story

Dutch Startups Secure Record Funding in Q4 2023, Scaling Challenges Persist

Latest from Blog

Majority secures $20M investment boost

Article Summary TLDR: Key Points: Majority, a Miami-based provider of mobile banking and international services for migrants, raised $20M in funding. The funding round included a mix of equity and debt financing
Go toTop